Protein Production Technology Podcast · FPG Media

Special Episode: Chris Bryant - APA

·33 min·2 clips

A one-page declaration signed by 1,000 scientists can still work as a lobbying tool, Chris says.

The show sits down with Chris Bryant, executive director of Bryant Research and a research advisor for the Alternative Proteins Association in the UK. He has spent years working through evidence on consumer attitudes, nutrition, and the societal impacts of alternative proteins. The conversation starts with why he entered the field. Bryant points to the way different disciplines come together around a protein system that could be more sustainable, efficient, and kind. The host then asks what he has learned after years of evidence work. Bryant's answer keeps returning to how public understanding is shaped as much by headlines as by research. The discussion moves into the challenge of explaining alternative proteins in a media environment already crowded with arguments about ultra-processed food. Bryant uses a hypothetical NHS-style program involving plant-based meat to show how many decision makers would be involved in a real-world rollout. That example makes the policy problem feel concrete. Even where institutional understanding exists, he argues, there is still a need to educate. The episode then turns to pushback from parts of the traditional livestock industry. Bryant criticizes the Dublin Declaration and similar efforts as examples of advocacy with strong industry connections. He does not treat those connections as automatically disqualifying. Instead, he says they tell you something about the purpose of the research. The conversation broadens into the way claims are framed and implied. Bryant argues that some arguments are never stated directly, but are clearly being suggested. When challenged, he notes, the authors often respond by denying that they said what they were implying. The episode stays focused on the gap between evidence, messaging, and agenda setting. It closes with Bryant looking ahead to the Future of Protein Production in Amsterdam, where he will chair a panel on the future of alternative proteins in Europe. The result is a steady, interview-led discussion that treats the protein transition as a scientific, commercial, and public-facing argument all at once.

As heard by us

A clear look at the evidence, the messaging, and the policy stakes around alternative proteins.

Chris Bryant treats the alternative protein debate as an evidence problem, not a slogan contest. He draws on work about consumer attitudes, nutrition, and the wider social effects of alternative proteins, while the discussion keeps circling back to how headlines and research…

Read the full review in PlayNext →

Why you'd press play

You want an evidence-led take on alternative proteins, not the slogans.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Protein Production Technology Podcast